Initial public offering of Calliditas Therapeutics AB (SE) on The Nasdaq Global Select Market US – USD 90 million Healthcare Initial public offering of Calliditas Therapeutics AB (SE) on The Nasdaq Global Select Market US – USD 90 million
Directed new share issue in Bambuser AB (SE) — SEK 290 million TMT Directed new share issue in Bambuser AB (SE) — SEK 290 million
Directed share issue in Intervacc AB — SEK 147 million Healthcare Directed share issue in Intervacc AB — SEK 147 million
New share issue in Storskogen Group AB (SE) — SEK 2 billion Industrials New share issue in Storskogen Group AB (SE) — SEK 2 billion
Listing of Genova Property Group AB (SE) on Nasdaq Stockholm Main Market Real Estate Listing of Genova Property Group AB (SE) on Nasdaq Stockholm Main Market
Sale of Kotikatu (FI) to Norvestor (NO) by Vaaka Partners (FI) — Amount not disclosed Business Services Sale of Kotikatu (FI) to Norvestor (NO) by Vaaka Partners (FI) — Amount not disclosed
Placing of shares in Paradox Interactive AB (SE) — SEK 941 million TMT Placing of shares in Paradox Interactive AB (SE) — SEK 941 million
Amendment to and extension of Strömma Turism & Sjöfart ABs senior unsecured 2016/2021 bonds — SEK 300 million Consumer & Retail Amendment to and extension of Strömma Turism & Sjöfart ABs senior unsecured 2016/2021 bonds — SEK 300 million
Amendment to and extension of Serneke Group ABs senior unsecured 2018/2021 bonds — SEK 700 million Real Estate Amendment to and extension of Serneke Group ABs senior unsecured 2018/2021 bonds — SEK 700 million
Placing of shares in Ambea AB (SE) — SEK 681 million Healthcare Placing of shares in Ambea AB (SE) — SEK 681 million
Directed share issue in Q-linea AB (SE) — SEK 270 million Healthcare Directed share issue in Q-linea AB (SE) — SEK 270 million
Directed share issue in NCAB Group AB (SE) — SEK 287 million Industrials Directed share issue in NCAB Group AB (SE) — SEK 287 million